Modified AKT Substrate II (A05-58C)
|
|
|
Catalog Number |
Pack Size |
Price (USD) |
|
|
| Modified AKT Substrate II |
A05-58C |
1 mg |
$95 |
|
Add to Cart |
| Modified AKT Substrate II |
A05-58C-BULK |
BULK |
CONTACT US |
|
|
|
|
* Prices listed in the "shopping cart" are not discount inclusive. Promotional Prices will be applied internally during the processing of orders and net totals adjusted accordingly.
Description: The Modified AKT Substrate II peptide sequence (modified-CKRPRAASFAE) is based on the N-terminus of GSK3.
| Tag: |
|
| Expression System: |
|
| Species: |
|
| Sequence: |
modified-CKRPRAASFAE |
| |
|
| |
|
Purity: Determined to be 95.6% by HPLC analysis.
Formulation: 1mg/ml of modified peptide solution was supplied.
Storage, Stability, and Shipping: Store product at –20oC. For optimal storage, aliquot diluted product into smaller quantities and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.
Applications: Kinase Assay
Molecular Weight: 1235.4
Modified AKT Substrate II Research Areas
The Modified AKT Substrate II product can be utilized in the following research areas, but not limited to:
AKT/PKB Pathway, Apoptosis/Autophagy, Cancer, Cardiovascular Disease, Inflammation, Metabolic Disorder, Neurobiology, NfkB Pathway, WNT Signaling